Indications
Active immunisation of ducks to prevent mortality1 and to reduce weight loss and lesions of duck parvovirosis and Derzsy's disease. 1In absence of maternally derived antibodies.
Composition
- Active substance
- live attenuated Muscovy duck parvovirus
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Parvoduk
- Active substance
- live attenuated Muscovy duck parvovirus
- Group
- Veterinary medicines
- Marketing authorisation holder
- Merial
- Status
- Lapsed
- EU authorisation
- 11 Apr 2014
- Withdrawn
- 1 Apr 2019
- EMA product number